Journal article
Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice
Abstract
Renal tubulointerstitial fibrosis is the common ending of progreβsive renal disease. It is worth developing new ways to stop the progreβs of renal fibrosis. Peroxisome proliferator-activated receptor-γ (PPARγ) agonists have been studied to treat diabetic nephropathy, cisplatin-induced acute renal injury, ischemia reperfusion injury and adriamycin nephropathy. In this study, unilateral ureteral obstruction (UUO) was used to establish a different …
Authors
Zhang Y; Wang J; Zhou Q-D; Zhang C-H; Li Q; Huang S; Zhan J; Wang K; Liu Y-Y; Xu G
Journal
Current Medical Science, Vol. 36, No. 1, pp. 41–47
Publisher
Springer Nature
Publication Date
February 2016
DOI
10.1007/s11596-016-1539-1
ISSN
2096-5230